SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company

2 years ago

DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) announces that three new members…

The Innovation Foundation, empowered by the Adecco Group, joins forces with Halixia

2 years ago

Launching the Mature Workers Programme LONDON, June 10, 2024 /PRNewswire/ -- Halixia, a purpose-based UK fintech dedicated to enhancing the…

Microsoft to help rural hospitals defend against rising cybersecurity attacks

2 years ago

New program will address exponential growth in attacks threatening access to care for Americans and bring enterprise-quality cybersecurity to the…

SCI Ventures Launches Venture Philanthropy Fund to Accelerate Restorative Treatments for Spinal Cord Injury and a Cure for Paralysis

2 years ago

Global early-stage fund to catalyze development of the next generation of treatments Backers include the leading spinal cord injury foundations…

XRP Healthcare Welcomes 10 Billion Dollar M&A Specialist Whitney Lynn to Head Africa Expansion

2 years ago

DUBAI, UAE, June 10, 2024 /PRNewswire/ -- XRP Healthcare, a trailblazer in the healthcare sector, is proud to announce the…

Defence to Participate in 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or…

Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity

2 years ago

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 10, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the…

Haoxi Health Technology Limited Facilitates International Humanitarian Aid Efforts Amid Global Challenges

2 years ago

BEIJING--(BUSINESS WIRE)--Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced…

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

2 years ago

Injection-free subgroup results demonstrated that a single intravitreal dose of 4D-150 without any supplemental anti-VEGF injections resulted in stable mean…

Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024

2 years ago

SOUTH SAN FRANCISCO, Calif., June 08, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing…